Last data update: Apr 06, 2020. (Total: 2840 publications since 2011)
|Query Trace: Cystic fibrosis[orginal query]|
| Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.
Lisa B Feng, Scott D Grosse, Ridgely Fisk Green, Aliza K Fink, and Gregory S Sawicki
Health affairs (Project Hope) 2018 May 37(5) 773-779
| The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
Scott D Grosse, John D Thompson, Yao Ding, and Michael Glass
The Milbank quarterly 2016 94(2) 366-91
| Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
Scott D Grosse
Healthcare (Basel, Switzerland) 2015 3(4) 1133-57
| Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
Mei W Baker, Anne E Atkins, Suzanne K Cordovado, Miyono Hendrix, Marie C Earley, and Philip M Farrell
Genet. Med. 2015 Feb 12.
| CFTR mutation analysis and haplotype associations in CF patients.
S K Cordovado, M Hendrix, C N Greene, S Mochal, M C Earley, P M Farrell, M Kharrazi, W H Hannon, and P W Mueller
Mol. Genet. Metab. 2012 Feb 105(2) 249-54
| Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.
Marie C Earley, Anita Laxova, Philip M Farrell, Rena Driscoll-Dunn, Suzanne Cordovado, Peter J Mogayzel, Michael W Konstan, and W Harry Hannon
Clin. Chim. Acta 2011 Jul 15. 412(15-16) 1376-81
| Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.
Steven J Korzeniewski, William I Young, Harry C Hawkins, Kevin Cavanagh, Samya Z Nasr, Carrie Langbo, Kelly R Teneyck, Scott D Grosse, Mary Kleyn, and Violanda Grigorescu
Pediatric pulmonology 2011 Feb 46(2) 125-30